Showing results (151-160 of 351) with videos related to

Sort By:
Pageof 36
Annals of Hematology|November 5, 2024
Beneficial effects of cellular immunotherapy in the prevention and treatment of posttransplant hematologic relapse of myelodysplastic neoplasmsGi-June Min, Sung Soo Park, Silvia Park, et al.
Tuberculosis and Respiratory Diseases|December 11, 2012
Prognosis of invasive pulmonary aspergillosis in patients with hematologic diseases in KoreaJae-Cheol Kwon, Si-Hyun Kim, Sun Hee Park, et al.
International Journal of Hematology|June 15, 2007
The beneficial effect of chronic graft-versus-host disease on the clinical outcome of transplantation with fludarabine/busulfan-based reduced-intensity conditioning for patients with de novo myelodysplastic syndromeByung-Sik Cho, Yoo-Jin Kim, Seok-Goo Cho, et al.
Blood Research|October 23, 2025
Tandem autologous stem cell transplant in multiple myeloma patients with minimal residual disease: an explorative studySieun Oh, Sung-Soo Park, Jung Yeon Lee, et al.
Hematological Oncology|March 19, 2015
Allogeneic stem cell transplantation using lymphoablative rather than myeloablative conditioning regimen for relapsed or refractory lymphomasJae-Ho Yoon, Young-Woo Jeon, Sung-Eun Lee, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 13, 2015
Bone marrow-derived progenitor cells in de novo liver regeneration in liver transplantSung-Gyu Lee, Sung-Hwan Moon, Hee-Je Kim, et al.
Medical Oncology (Northwood, London, England)|August 18, 2010
FLANG salvage chemotherapy is an effective regimen that offers a safe bridge to transplantation for patients with relapsed or refractory acute myeloid leukemiaKi-Seong Eom, Woo-Sung Min, Hee-Je Kim, et al.
The Korean Journal of Internal Medicine|September 2, 2009
Bone marrow T cells are superior to splenic T cells to induce chimeric conversion after non-myeloablative bone marrow transplantationHyun-Sil Park, Seok-Goo Cho, Min-Jung Park, et al.
Blood Advances|February 22, 2023
TAK-981, a SUMOylation inhibitor, suppresses AML growth immune-independentlyHan Sun Kim, Bo-Reum Kim, Thien T P Dao, et al.
Haematologica|September 15, 2018
Treatment outcomes and prognostic factors in adult patients with secondary hemophagocytic lymphohistiocytosis not associated with malignancyJae-Ho Yoon, Sung-Soo Park, Young-Woo Jeon, et al.
Pageof 36